YEM Search

搜索结果

AOX1

靶点ID:TCMBANKGE013220

靶点别名:AO; AOH1

靶点描述:aldehyde oxidase 1

染色体:2

染色体位置:2q33.1

靶点类型:protein-coding

HERB_ID:-

HGNC_Link:553

OMIM_Link:602841

Ensembl_Link:ENSG00000138356

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN003665	evoden				C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O
TCMBANKIN003873	ranachrome 3		C7H7N5O2	193.16 g/mol	C1=C(N=C2C(=O)NC(=NC2=N1)N)CO
TCMBANKIN040799	Santin			344.3 g/mol
TCMBANKIN058277	2-hydroxybenzoic acid	O-hydroxybenzoic acid; 3- coffee acid; Thick-stemmed black base	C7H6O3 or HOC6H4COOH	138.12 g/mol	C1=CC=C(C(=C1)C(=O)O)O
TCMBANKIN058372	indole-3-carboxaldehyde	3-Formylindole; Indole-3-carbaldehyde; beta-Indolylaldehyde; 3-Indolealdehyde; 246045-99-8; SBB004120; AI3-52407; Indol-3-carboxaldehyde; NSC10118; 487-89-8; BRN 0114117; 5-21-08-00246 (Beilstein Handbook Reference); 1H-indole-3-carbaldehyde; 3-formylindole; 1H-Indole-3-carboxaldehyde; C08493; AIDS-019632; Indole-3-carboxaldehyde; 3-Indolecarboxaldehyde; INDOLE-3-CARBOXYALDEHYDE; .beta.-Indolylaldehyde; EINECS 207-665-8; AIDS019632; NSC 10118; 57210_FLUKA; 3-Indolecarbaldehyde; ZINC00087959; NCGC00161738-01; BAS 07339836; INDOLE-3-ALDEHYDE; 129445_ALDRICH	C9H7NO	145.16 g/mol	C1=CC=C2C(=C1)C(=CN2)C=O
TCMBANKIN058454	glaunine	guanine (1,7-dihydro-form)	C5H5N5O		C1=NC2=C(N1)C(=O)N=C(N2)N
TCMBANKIN061473	Isovanillin	3-Hydroxy-4-anisaldehyde; 3-Hydroxy-4-methoxybenzaldehyde; FT-0615821; ANW-34085; 4-Methoxy-3-hydroxy-benzaldehyde; DSSTox_RID_83498; ACMC-209n07; 4-methoxy-5-hydroxybenzaldehyde; NCGC00247609-01; BR-26987; SMR000156287; 143685_ALDRICH; BG01499429; CHEMBL275563; AK-26987; SBB008245; SC-05820; Q-100718; 3-Hydroxy-4-methoxybenzaldehyde; 3-hydroxy-4-anisaldehyde; MCULE-7646011311; 621-59-0; PubChem7770; F1995-0251; RTC-060637; 3-hydroxy-4-methoxy- benzaldehyde; 3-hydroxy-4-methoxy- benzaldehyde;BB_NC-2245; 3-Hydroxyanisaldehyde; AJ-16240; DSSTox_GSID_49423; 4A9N90H9X6; PS-4589; Isovanilline; 3-Hydroxy-para-anisaldehyde; MolPort-000-146-016; 3-hydroxy-4methoxy-benzaldehyde; NSC82996; SCHEMBL70256; BC204204; JVTZFYYHCGSXJV-UHFFFAOYSA-N; Tox21_202858; 4-Methoxy-3-hydroxybenzaldehyde; KS-000002MN; DTXSID7049423; 3-hydroxy-4-methoxy benzaldehyde; p-Anisaldehyde, 3-hydroxy- (8CI); Benzaldehyde, 3-hydroxy-4-methoxy-; AN-15747; D0E9CD; EBD684885; isovanillin; I0519; LS10550; A833619; 59927_FLUKA; HMS3348H19; Isovanicaline; 4-methoxy-3-oxidanyl-benzaldehyde; 3-Hydroxy-4-methoxy-benzaldehyde; LS-25072; 4-08-00-01764 (Beilstein Handbook Reference); HMS2194I16; AC-541; KSC354M3B; ZINC164617; Isovanillin, >=95.0%; ISOVANILLIN; ST50213460; I01-0153; BBL023550; NCGC00260404-01; BG00600677; NSC 82996; WLN: VHR CQ DO1; isovanilin; BRN 1073021; NSC-82996; 3-hydroxy-4-methoxy-benzaldehyde; CJ-02189; ZB008229; MLS000574853; Oxy-3 methoxy-4 benzaldehyde; DSSTox_CID_29383; CS-W009023; NCIOpen2_001085; 3-Hydroxy-4-methoxybenzaldehyde, 99%; DB-010058; 3-Hydroxyanisaldehyde; Isovanillin; 59940_FLUKA; ST24022906; AC1Q469E; STK400134; TRA0093875; InChI=1/C8H8O3/c1-11-8-3-2-6(5-9)4-7(8)10/h2-5,10H,1H; AKOS000120260; 3-hydroxy4-methoxybenzaldehyde; M-6105; CAS-621-59-0; TC-060637; TL8004050; AB1002458; CM13992; Oxy-3 methoxy-4 benzaldehyde [French]; p-Anisaldehyde, 3-hydroxy-; CTK2F4630; iso-Vanillin; AC1L1YWO; 5-Formylguaiacol; FT-0615853; 21I590; isovaniline; ZINC00164617; RP21587; KB-32136; BDBM50240367; 3-Hydroxy-p-anisaldehyde; P-Anisaldehyde, 3-hydroxy-(8CI); UNII-4A9N90H9X6; EINECS 210-694-9; MFCD00003369	C8H8O3	152.15	COC1=C(C=C(C=C1)C=O)O
TCMBANKIN061663	axillarin	3',4',5,7-Tetrahydroxy-3,6-dimethoxyflavone; axillarin ; DTXSID80199840; NCGC00168986-01; C10021; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-; CHEBI:2941; DMQT; Axillarin; 3',4',5,7-tetrahydroxy-3,6-dimethoxy-flavone; MCULE-1507651933; MEGxp0_000118; CHEMBL487810; AC1NQYPJ; 5188-73-8; 3,6-Dimethoxy-5,7,3',4'-tetrahydroxyflavone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxychromen-4-one; BDBM50242286; 3,6-Dimethoxyquercetagetin; ACon1_000535; SCHEMBL1155670; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-4H-chromen-4-one; Quercetagetin 3,6-dimethyl ether; NCGC00168986-02!2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxychromen-4-one; NP-000321; LMPK12112990; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-4H-1-benzopyran-4-one;ACon1_000535; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-chromone; 5188-73-8; 3',4',5,7-Tetrahydroxy-3,6-dimethoxyflavone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxychromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-; Quercetagetin 3,6-dimethyl ether; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-4-chromenone; Axillarin; C10021; 3,6-Dimethoxyquercetagetin; MEGxp0_000118; DMQT	C17H14O8	346.3 g/mol	COC1=C(C2=C(C=C1O)OC(=C(C2=O)OC)C3=CC(=C(C=C3)O)O)O

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI002512		Digestive System Diseases	Abnormality of the digestive system; Abnormality of the immune system	Disease or Syndrome	disease
TCMBANKDI007091		Neoplasms	-	Neoplastic Process	phenotype
TCMBANKDI011712		Neoplasms; Nervous System Diseases	-	Neoplastic Process	group
TCMBANKDI018731		Digestive System Diseases	Abnormality of the digestive system	Disease or Syndrome	disease
TCMBANKDI019267		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Sign or Symptom	phenotype